Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Common Equity (2016 - 2025)

Hypha Labs (FUNI) has disclosed Common Equity for 15 consecutive years, with -$2.1 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Common Equity fell 108.6% year-over-year to -$2.1 million, compared with a TTM value of -$2.1 million through Jun 2025, down 108.6%, and an annual FY2024 reading of -$1.3 million, up 42.85% over the prior year.
  • Common Equity was -$2.1 million for Q2 2025 at Hypha Labs, down from -$1.8 million in the prior quarter.
  • Across five years, Common Equity topped out at -$471661.0 in Q1 2024 and bottomed at -$2.9 million in Q1 2023.
  • Average Common Equity over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2022.
  • The sharpest move saw Common Equity plummeted 685.76% in 2021, then surged 83.78% in 2024.
  • Year by year, Common Equity stood at -$1.5 million in 2021, then crashed by 89.17% to -$2.9 million in 2022, then grew by 28.76% to -$2.1 million in 2023, then increased by 23.77% to -$1.6 million in 2024, then tumbled by 32.07% to -$2.1 million in 2025.
  • Business Quant data shows Common Equity for FUNI at -$2.1 million in Q2 2025, -$1.8 million in Q1 2025, and -$1.6 million in Q4 2024.